November 1, 2014

Biotechnology, Food & Drug Administration FDA News

Syndicate content

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
31
Oct
FDA and the Center for Food Safety Reach Settlement Regarding FDA’s GRAS Rule Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
30
Oct
Ariosa Diagnostics v. Verinata Health, Inc.: Final Written Decision IPR2014-00276 Drinker Biddle & Reath LLP
30
Oct
Biometric Screening Requirement Under Wellness Program Violates ADA and GINA, According to EEOC Suit Jackson Lewis P.C.
30
Oct
Medical Device Update: Distinguishing Medical Device Recalls from Medical Device Enhancements Morgan, Lewis & Bockius LLP
29
Oct
Marijuana Users in Michigan Eligible for Unemployment Proskauer Rose LLP
29
Oct
Progress Update: House Energy and Commerce Committee (E&C) 21st Century Cures Initiative McDermott Will & Emery
29
Oct
Ebola Exclusions from Commercial Insurance Policies Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
29
Oct
U.S. Immigration Policy Catches Up with Assisted Reproductive Technology Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
29
Oct
Recent Trends in Medical Device Patent Litigation at the ITC — Part 1 Covington & Burling LLP
29
Oct
Government Looking to Existing Procurement Vehicles to Stem Ebola Threat Covington & Burling LLP
28
Oct
Texas Federal Jury Sides with J&J’s DePuy In First Pinnacle Hip Implant Trial Covington & Burling LLP
28
Oct
CMS Releases Preliminary 2015 Clinical Laboratory Fee Schedule Rates McDermott Will & Emery
28
Oct
Bostwick Laboratories Agrees to Pay U.S. Government $6.05 Million for Allegedly Violating the Anti-Kickback Statue; Whistleblower to Receive Reward Tycko & Zavareei LLP
28
Oct
Michigan Medical Marijuana Law Allows Employees Terminated for Positive Marijuana Test Results to Receive Unemployment Benefits Jackson Lewis P.C.
27
Oct
A Review of the Status of Biosimilars in the U.S. Michael Best & Friedrich LLP
25
Oct
EPA Updates Toxic Substances Control Act (TSCA) Work Plan for Chemical Assessments Beveridge & Diamond PC
24
Oct
FTC Takes Action Against Unsubstantiated Caffeine-Infused Shapewear Weight-Loss Claims Sheppard, Mullin, Richter & Hampton LLP
23
Oct
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 23, 2014 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
23
Oct
Uncertain Times for Biotech and Pharma Patents Vedder Price
23
Oct
California Battle of the Experts Still Brewin’ in Starbucks Trial Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Advertisement

LATEST LEGAL NEWS & ANALYSIS

Womble Carlyle Sandridge & Rice, PLLC
McDermott Will & Emery
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Thursday, November 13, 2014
Tuesday, November 18, 2014